Skip to main content
. 2021 Sep 4;23:231. doi: 10.1186/s13075-021-02613-9

Fig. 2.

Fig. 2

Proportion of patients achieving ASAS40 response in the overall population through week 16. *P < 0.0001, P < 0.001, §P < 0.01, P < 0.05 versus placebo. Data presented as NRI through week 16. ASAS, Assessment of SpondyloArthritis international Society; CRP, C-reactive protein; MRI, magnetic resonance imaging; N, total number of patients; NRI, non-responder imputation